Data as of May 17
| -0.02 / -3.39%|
The 4 analysts offering 12-month price forecasts for Aastrom Biosciences Inc have a median target of 0.83, with a high estimate of 3.00 and a low estimate of 0.25. The median estimate represents a +44.74% increase from the last price of 0.57.
The current consensus among 6 polled investment analysts is to Hold stock in Aastrom Biosciences Inc. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.